| Return Create A Forum - Home | |
| --------------------------------------------------------- | |
| MS Speaks | |
| https://msspeaks.createaforum.com | |
| --------------------------------------------------------- | |
| ***************************************************** | |
| Return to: PLEGRIDY (pegylated interferon beta-1a) | |
| ***************************************************** | |
| #Post#: 519-------------------------------------------------- | |
| Plegridy to cost $62,036/year--same as Avonex | |
| By: agate Date: October 16, 2014, 8:02 pm | |
| --------------------------------------------------------- | |
| Excerpted from the Boston Globe, October 4, 2014: | |
| [quote]Biogen�s new MS drug to cost $62,036 a year | |
| By Robert Weisman | GLOBE STAFF | |
| Cambridge biotech Biogen Idec Inc. said Friday it will charge | |
| $62,036 per patient for a year�s treatment with its newly | |
| approved multiple sclerosis drug Plegridy. | |
| The list price of Plegridy, a new type of injectable drug that | |
| treats adults with the most common form of MS, is identical to | |
| that of Biogen Idec�s original injectable, Avonex, which is | |
| still on the market. | |
| Plegridy, a longer-lasting drug for patients with | |
| relapsing-remitting MS, was approved by the Food and Drug | |
| Administration on Aug. 15 for US sale. Biogen Idec disclosed the | |
| price Friday before releasing the drug to distributors. | |
| �We�re pricing for the innovation,� said Biogen Idec spokeswoman | |
| Kate Niazi-Sai. �But we�re also pricing to make sure patients | |
| have access to it and the system can support it. That�s a | |
| balance, and that�s what we�re trying to do here.� | |
| Drug pricing has become a hot button issue in an era of rising | |
| health costs. | |
| ... | |
| Biogen Idec�s own pill to treat MS, called Tecfidera, costs | |
| $60,121 a year. | |
| Plegridy, the latest addition to Biogen Idec�s portfolio of MS | |
| medicines, also has been approved by the European Commission for | |
| sale in 28 countries across the Atlantic. | |
| ... | |
| Plegridy has the same active ingredient, interferon beta, as | |
| Avonex. But the company attached a polymer called polyethylene | |
| glycol, or peg, to Plegridy that increases the exposure of the | |
| drug, allowing patients to take doses less frequently. While | |
| Avonex has to be injected into the muscle once a week, Plegridy | |
| can be taken by injection every two weeks, administered under | |
| the skin with an auto-injector. | |
| Biogen Idec hopes to transition many patients over time from | |
| Avonex and other first-generation interferons, some of which | |
| have to be injected three times a week, to the longer-lasting | |
| drug Plegridy. But the company has no plans to discontinue the | |
| sale of Avonex.[/quote] | |
| The entire article can be seen here | |
| http://www.bostonglobe.com/business/2014/10/03/biogen-idec-prices-new-multiple-… | |
| ***************************************************** |